Gain Therapeutics, Inc. (NASDAQ:GANX) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of shares of common stock and warrants to purchase common stock Announced: about US$7M · US$3.11 a share · 1 warrant at US$1.65 for 60 months · Newbridge Securities Corporation Dealers: Newbridge Securities Corporation (lead) Use of proceeds: Clinical and nonclinical development of lead candidate GT-02287 for neurodegenerative diseases including GBA1 Parkinson's, and general corporate purposes | Jul 16, 2025 |